Dr. Douglas Lucas
speaker
736 appearances
1 recordings
1 series
first heard Jul 2026
last heard 28 Jul
Dr. Douglas Lucas’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Jul 2026 with 1.
Appearances
If you go on, let's call it Prolia, and your T-score goes from negative three to negative two, you still have osteoporosis, even though you don't meet the criteria for it anymore.
But if you flip that script, and same thing with that diabetic, that person that has high blood pressure, you look for the underlying cause, it's a different conversation.
Yeah.
So ultimately, the question is fracture risk, right?
We use bone density to help to understand, or you could call that bone quantity, right?
We use density, quantity, same thing, to help to predict fracture risk.
But really, the fracture risk equation is bone quantity plus bone quality.
Equals fracture risk.
So it's density and quality.
Or density and strength is another way to say it.
And this is why it gets confusing.
There's all these terms.
But ultimately, it's more than just the quantity.
It's more than just the density.
It is the quality.
So then to get to your question with the drugs, yes, if you use an anti-resorptive drug and you suppress bone building and bone breakdown, your bone will continue to calcify.
It will continue to mineralize.
So it will get more dense.
And in the short term, that does decrease fracture risk.
But the challenge is, is what happens in the long term?
Showing 161–180 of 736 · page 9 of 37
← Previous
Next →